National Health Investors Inc (NHI)

National Health Investors Inc (NYSE-NHI) is a health care REIT common stock listed on the NYSE. The National Health Investors Inc security is a real estate investment trust instrument, so it should be understood as an equity interest in a property-focused vehicle rather than a traditional operating company. Its business context is tied to healthcare real estate and related financing activity, with exposure to senior housing and medical-related property types. As a REIT, the security is shaped by the company’s real estate holdings and lease or financing arrangements within that sector.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-NHI
$68.51
1.0% Upside
Fair
$81.88
20.8% Upside
Undervalued
Good
September 30, 2026
November 6, 2026
5.4%
November 10, 2026
20.4x
2.2x
7.8x
3.33 B
4.666 B
27.2%
97.6%
1.9
105.3%
149.3%
Valuation • Fair Value

National Health Investors Inc (NYSE-NHI) Fair Value by Valuation Model

Review the available estimates for National Health Investors Inc (NYSE-NHI), including Ben Graham Formula Value, DDM Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$68.51

Estimated upside of 1.0% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

Ben Graham Formula Value

$37.62

Classic Ben Graham valuation formula reference.

DDM Fair Value

$56.07

Dividend discount model valuation reference.

Comps Fair Value

$74.73

Comparable-company valuation reference.

Analyst Price Target

$81.88

Analysts imply upside of 20.8%.

How to read these valuation models

Use the 6 available valuation references for National Health Investors Inc (NYSE-NHI) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for National Health Investors Inc (NYSE-NHI)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

435.8 M

Current operating scale indicator.

Revenue Forecast

452.8 M

Forward revenue estimate.

EBITDA

289.7 M

Current operating profitability reference.

EBITDA Forecast

294.4 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review National Health Investors Inc (NYSE-NHI) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for National Health Investors Inc (NYSE-NHI)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-2.65

No elevated caution signal from this screen.

Altman Z-Score

1.9

Intermediate risk zone.

FCF / Net Income

149.3%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for National Health Investors Inc (NYSE-NHI). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for National Health Investors Inc (NYSE-NHI)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 10, 2026

Days to Earnings

53

Dividend Payment Date

November 6, 2026

Ex-Dividend Date

September 30, 2026

Dividend Yield

5.4%

Current income yield reference.

Payout Ratio

105.3%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for National Health Investors Inc (NYSE-NHI), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

National Health Investors Inc (NYSE-NHI) Stock Forecast & Technical Outlook

Review National Health Investors Inc (NYSE-NHI) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for National Health Investors Inc (NYSE-NHI) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for National Health Investors Inc (NYSE-NHI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for National Health Investors Inc (NYSE-NHI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for National Health Investors Inc (NYSE-NHI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for National Health Investors Inc (NYSE-NHI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for National Health Investors Inc (NYSE-NHI)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Buy

Based on the available recommendation mix, National Health Investors Inc (NYSE-NHI) has a Buy consensus, with 5 buy, 3 hold and 0 sell recommendations in the current data set.

Buy 5
Hold 3
Sell 0
FAQ Fast Investor Answers

National Health Investors Inc (NYSE-NHI) Stock FAQ

Data-supported answers about National Health Investors Inc (NYSE-NHI), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$68.51
Estimated upside 1.0%
Valuation Rating
Near Fair Value
Price is close to fair value
Analyst Target
$81.88
Implied upside 20.8%
Financial Health
Good
Current financial-health read

The current fair value estimate for National Health Investors Inc (NYSE-NHI) is $68.51. This implies an estimated upside of 1.0% versus the current market price.

Based on the current fair value estimate, the stock is trading close to its estimated fair value.

The available analyst price target for National Health Investors Inc (NYSE-NHI) is $81.88. The analyst target implies estimated upside of 20.8%.

The current financial health read for National Health Investors Inc (NYSE-NHI) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for National Health Investors Inc (NYSE-NHI) is November 10, 2026.

Based on the current data, dividend yield is 5.4%, ex-dividend date is September 30, 2026, payment date is November 6, 2026.

The current P/E ratio listed for National Health Investors Inc (NYSE-NHI) is 20.4x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for National Health Investors Inc is 3.33 B.

The current enterprise value listed for National Health Investors Inc is 4.666 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for National Health Investors Inc is NYSE-NHI, and the stock is listed on NYSE.

National Health Investors Inc (NYSE-NHI) is listed on NYSE.

The current debt-to-total-capital ratio listed for National Health Investors Inc is 27.2%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for National Health Investors Inc is 97.6%. Free float helps investors understand how much of the share base is available for public trading.